Your prediction
Pros and Cons of Amp Ltd. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amp Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amp Ltd. | 4.550% | -2.222% | 28.155% | 46.667% | 28.155% | 104.651% | 101.527% |
| National Australia Bank | -0.460% | 4.573% | 11.037% | 21.087% | 9.307% | 56.469% | 57.494% |
| Commonwealth Bank Australia | 0.920% | 0.314% | 6.353% | 9.931% | 18.273% | 78.774% | 66.892% |
| Macquarie Group Ltd | 0.160% | 4.318% | 3.098% | 33.617% | 38.222% | 54.250% | 64.012% |
News
Ardagh Metal Packaging Q2 Earnings Call Highlights
Key Points
- Interested in Ardagh Metal Packaging S.A.? Here are five stocks we like better.
- Ardagh Metal Packaging raised full-year 2026 adjusted EBITDA guidance to $775 million-$790 million
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
Key Points
- Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amphastar is shifting its strategy from complex generics toward proprietary drugs and
Pennon Group H2 Earnings Call Highlights
Key Points
- Interested in Pennon Group Plc? Here are five stocks we like better.
- Pennon returned to profitability in 2025/2026, with EBITDA up 55% and underlying operating profit more than